Patent Assignment
Reel/Frame 064256/0503
Change of Name
Recorded: 2023-07-12
Pages: 18
Assignor
SHANGHAI HAIHE PHARMACEUTICAL CO., LTD.
Executed: 2020-11-13
Assignee
HAIHE BIOPHARMA CO., LTD.
UNIT 102, 1/F, BLDG. 1; 2/F-6/F, BLDG. 1; 4/F, BLDG. 2, NO. 865 ZUCHONGZHI ROAD, PILOT FREE TRADE ZONE, SHANGHAI, 201203, CHINA
Covered Property
(1)
Compound Having Erk Kinase Inhibitory Activity and Use Thereof
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 2, 2022
From: GENG, MEIYU; DING, JIAN; HUANG, MIN; TANG, SHUAI
To: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
Reel/Frame 059780/0685 →
Assignment of Assignor's Interest
May 2, 2022
From: LI, LEI; ZHANG, QIONG; HUANG, YING
To: SHANGHAI HAIHE PHARMACEUTICAL CO., LTD.
Reel/Frame 059780/0693 →
Assignment of Assignor's Interest
Jul 12, 2023
From: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
To: HAIHE BIOPHARMA CO., LTD.
Reel/Frame 064222/0029 →